Homozygous Dkk1 Knockout Mice Exhibit High Bone Mass Phenotype Due to Increased Bone Formation

被引:0
|
作者
Michelle M. McDonald
Alyson Morse
Aaron Schindeler
Kathy Mikulec
Lauren Peacock
Tegan Cheng
Justin Bobyn
Lucinda Lee
Paul A. Baldock
Peter I. Croucher
Patrick P. L. Tam
David G. Little
机构
[1] The Children’s Hospital at Westmead,Orthopaedic Research & Biotechnology Unit
[2] The Garvan Institute for Medical Research,Bone Biology Division
[3] University of Sydney,Discipline of Paediatrics and Child Health, Sydney Medical School
[4] The Children’s Medical Research Institute,Embryology Unit
[5] University of Sydney,Discipline of Anatomy and Histology, School of Medical Sciences, Sydney Medical School
来源
关键词
Dkk1; Wnt-signalling; Bone; High bone mass; Knockout model;
D O I
暂无
中图分类号
学科分类号
摘要
Wnt antagonist Dkk1 is a negative regulator of bone formation and Dkk1+/− heterozygous mice display a high bone mass phenotype. Complete loss of Dkk1 function disrupts embryonic head development. Homozygous Dkk1−/− mice that were heterozygous for Wnt3 loss of function mutation (termed Dkk1 KO) are viable and allowed studying the effects of homozygous inactivation of Dkk1 on bone formation. Dkk1 KO mice showed a high bone mass phenotype exceeding that of heterozygous mice as well as a high incidence of polydactyly and kinky tails. Whole body bone density was increased in the Dkk1 KO mice as shown by longitudinal dual-energy X-ray absorptiometry. MicroCT analysis of the distal femur revealed up to 3-fold increases in trabecular bone volume and up to 2-fold increases in the vertebrae, compared to wild type controls. Cortical bone was increased in both the tibiae and vertebrae, which correlated with increased strength in tibial 4-point bending and vertebral compression tests. Dynamic histomorphometry identified increased bone formation as the mechanism underlying the high bone mass phenotype in Dkk1 KO mice, with no changes in bone resorption. Mice featuring only Wnt3 heterozygosity showed no evident bone phenotype. Our findings highlight a critical role for Dkk1 in the regulation of bone formation and a gene dose-dependent response to loss of DKK1 function. Targeting Dkk1 to enhance bone formation offers therapeutic potential for osteoporosis.
引用
收藏
页码:105 / 116
页数:11
相关论文
共 50 条
  • [21] Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume
    Morse, Alyson
    Cheng, Tegan L.
    Schindeler, Aaron
    McDonald, Michelle M.
    Mohanty, Sindhu T.
    Kneissel, Michaela
    Kramer, Ina
    Little, David G.
    CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (03) : 298 - 310
  • [22] Reduction of the WnT inhibitor Dkk1 correlates with improved bone mechanical and morphological properties in mice
    Joiner, Danese M.
    MacDonald, Bryan T.
    He, Xi
    Hauschka, Peter V.
    Goldstein, Steven A.
    PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, 2007, : 859 - 860
  • [23] Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions
    Washio-Oikawa, Kaoru
    Nakamura, Takahisa
    Usui, Michihiko
    Yoneda, Mitsuhiro
    Ezura, Youichi
    Ishikawa, Isao
    Nakashima, Kazuhisa
    Noda, Tetsuo
    Yamamoto, Tadashi
    Noda, Masaki
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (08) : 1217 - 1223
  • [24] Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice
    Yao, Gang-Qing
    Wu, Jian-Jun
    Troiano, Nancy
    Insogna, Karl
    JOURNAL OF BONE AND MINERAL METABOLISM, 2011, 29 (02) : 141 - 148
  • [25] Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice
    Gang-Qing Yao
    Jian-Jun Wu
    Nancy Troiano
    Karl Insogna
    Journal of Bone and Mineral Metabolism, 2011, 29 : 141 - 148
  • [26] Heterozygous PPARγ-deficient mice exhibit high bone mass with increased osteoblastic differentiation from bone marrow progenitors.
    Akune, T
    Kubota, N
    Harada, Y
    Azuma, Y
    Kadowaki, T
    Nakamura, K
    Kawaguchi, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S137 - S137
  • [27] Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
    Heath, Deborah J.
    Chantry, Andrew D.
    Buckle, Clive H.
    Coulton, Les
    Shaughnessy, John D., Jr.
    Evans, Holly R.
    Snowden, John A.
    Stover, David R.
    Vanderkerken, Karin
    Croucher, Peter I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (03) : 425 - 436
  • [28] Effects of adipocyte-specific Dkk1 deletion on bone homeostasis and obesity-induced bone loss in male mice
    Daamouch, Souad
    Thiele, Sylvia
    Hofbauer, Lorenz
    Rauner, Martina
    ENDOCRINE CONNECTIONS, 2023, 12 (11)
  • [29] An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling
    Gretl Hendrickx
    Eveline Boudin
    Ligia Mateiu
    Timur A. Yorgan
    Ellen Steenackers
    Michaela Kneissel
    Ina Kramer
    Geert Mortier
    Thorsten Schinke
    Wim Van Hul
    Calcified Tissue International, 2024, 114 : 171 - 181
  • [30] An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling
    Hendrickx, Gretl
    Boudin, Eveline
    Mateiu, Ligia
    Yorgan, Timur A.
    Steenackers, Ellen
    Kneissel, Michaela
    Kramer, Ina
    Mortier, Geert
    Schinke, Thorsten
    Van Hul, Wim
    CALCIFIED TISSUE INTERNATIONAL, 2024, 114 (02) : 171 - 181